|
|
| | HC-5404-Fu Basic information |
| Product Name: | HC-5404-Fu | | Synonyms: | HC-5404-Fu;3-Pyridinecarboxamide, 2-amino-5-[4-[[(2R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino]-2-methylphenyl]-N-(1-methylethyl)-, (2E)-2-butenedioate (2:1) | | CAS: | 3034479-99-4 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![HC-5404-Fu Structure]() |
| | HC-5404-Fu Chemical Properties |
| form | Solid | | color | White to off-white |
| | HC-5404-Fu Usage And Synthesis |
| Uses | HC-5404-Fu is a PERK inhibitor with an antitumor activity. HC-5404-Fu inhibits endoplasmic reticulum stress response signalling. HC-5404-Fu sensitizes renal cell carcinoma cells to vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitors (TKIs). HC-5404-Fu is promising for research of renal cell carcinoma, gastric cancer, metastatic breast cancer, small cell lung cancer, and other solid tumors[1][2][3]. | | References | [1] Lines CL, et al. The integrated stress response in cancer progression: a force for plasticity and resistance. Front Oncol. 2023 Aug 3;13:1206561. DOI:10.3389/fonc.2023.1206561
[2] Al-Rawi DH, et al. Targeting chromosomal instability in patients with cancer. Nat Rev Clin Oncol. 2024 Sep;21(9):645-659. DOI:10.1038/s41571-024-00923-w
[3] Al Azzani M, et al. Phytochemical-mediated modulation of autophagy and endoplasmic reticulum stress as a cancer therapeutic approach. Phytother Res. 2024 Jul 3. DOI:10.1002/ptr.8283 |
| | HC-5404-Fu Preparation Products And Raw materials |
|